| Preferred Name |
HMG-CoA Reductase Inhibitor |
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1655 |
| ALT_DEFINITION |
Any of a group of drugs that lower the amount of cholesterol and certain fats in the blood. Statins inhibit a key enzyme that helps make cholesterol. Statin drugs are being studied in the prevention and treatment of cancer. Compounds that inhibit HMG-CoA reductases. They have been shown to directly lower cholesterol synthesis. |
| CHEBI_ID |
CHEBI:35664 |
| code |
C1655 |
| DEFINITION |
Any substance that inhibits HMG-CoA reductase, a key enzyme in cholesterol synthesis. Inhibition of HMG-CoA reductase acts to lower plasma cholesterol and lipoprotein levels. |
| FULL_SYN |
hydroxymethylglutaryl-coenzyme A reductase inhibitor Hydroxymethylglutaryl CoenzymeA Reductase Inhibitors Statin |
| label |
HMG-CoA Reductase Inhibitor |
| Legacy_Concept_Name |
HMG-CoA_Reductase_Inhibitor |
| Preferred_Name |
HMG-CoA Reductase Inhibitor |
| prefixIRI |
C1655 |
| prefLabel |
HMG-CoA Reductase Inhibitor |
| Semantic_Type |
Chemical Viewed Functionally |
| UMLS_CUI |
C0360714 |
| subClassOf |
| Delete | Mapping To | Ontology | Source |
|---|---|---|---|
| There are currently no mappings for this class. | |||